Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Therapeutic Potential
100%
Pien Tze Huang
100%
Experimental Autoimmune Encephalomyelitis
100%
Central Nervous System
50%
Multiple Sclerosis
37%
Myelin Basic Protein
37%
Olig2
25%
Lewis Rats
12%
Therapeutic Effect
12%
P-STAT3
12%
Traditional Chinese Medicine
12%
Anti-inflammatory Effect
12%
Clinical Symptoms
12%
Neuroprotective Effect
12%
Inflammatory Chemokines
12%
CCL5
12%
Feature Level
12%
Inflammatory Cell Infiltration
12%
Interleukin-17 (IL-17)
12%
Immunoregulatory Effect
12%
Histopathological Features
12%
Interleukin-23 (IL-23)
12%
Commercially Viable
12%
Protein-peptide Complexes
12%
P-p65
12%
Clinical Severity
12%
CCL3
12%
Central Nervous System Demyelinating Diseases
12%
Chronic Inflammatory Demyelinating
12%
Demyelinating Diseases
12%
Organ Coefficient
12%
Immunology and Microbiology
Experimental Autoimmune Encephalomyelitis
100%
Central Nervous System
83%
Myelin
50%
Multiple Sclerosis
50%
STAT3
16%
Chemokine
16%
Peptides
16%
Proinflammatory Cytokine
16%
Inflammatory Cell
16%
Lewis Rat
16%
CCL3
16%
Cell Infiltration
16%
CCL5
16%
Clinically Isolated Syndrome
16%
Pharmacology, Toxicology and Pharmaceutical Science
Experimental Autoimmune Encephalomyelitis
100%
Multiple Sclerosis
50%
Myelin Basic Protein
50%
Traditional Chinese Medicine
16%
Cytokine
16%
Lewis Rat
16%
Therapeutic Effect
16%
Neuroprotective Agent
16%
Chemokine
16%
Anti-Inflammatory Drug
16%
Demyelinating Disease
16%